In obesity, lower lipogenesis might reflect an impaired ability to synthesize and store TGs due to associated metabolic stress or hormonal imbalances (55), while enhanced lipolysis may suggest an increased breakdown of stored TGs driven by elevated adipose tissue inflammation, insulin resistance, or heightened catecholamine activity (56–58). The gene discussed is INS; the disease is obesity disorder.